Allurion Technologies’ CFO, Christopher Geberth, is resigning to explore new opportunities, effective November 13, 2024, but will continue as a consultant during the transition. CEO Shantanu ...

In other recent news, Allurion Technologies reported its fourth-quarter 2024 earnings, revealing a decrease in revenue to $5.6 million from $8.2 million in the same quarter of the previous year.

Weight-loss tech company Allurion Technologies has expanded its board ... Richey has served as president and CEO of Woburn-based medical technology company Cytrellis Biosystems and in several ...

The CEO of Allurion, Dr. Shantanu Gaur ... in obesity care if the study confirms the preliminary findings. Allurion Technologies is focused on ending obesity through its innovative weight-loss ...

Allurion Technologies, Inc. (NYSE ... Shantanu Gaur, Allurion's Founder and CEO, expressed confidence in the company's growing patent collection, emphasizing its role in supporting the company's ...

Allurion Technologies ALUR shares are moving higher ... maintaining or even increasing muscle mass. Dr. Shantanu Gaur, CEO of Allurion, stated that the planned study aims to confirm whether ...

Dr. Shantanu Gaur, Allurion Technologies Inc. (NYSE:ALUR)’s Founder and CEO, expressed enthusiasm about returning to the French market, emphasizing the company’s commitment to metabolically ...

Allurion Technologies (NYSE ... Dr. Shantanu Gaur, Founder and CEO of Allurion, emphasized the significance of maintaining lean muscle mass during weight loss. He highlighted the potential ...

Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock Open in App ...

Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock View all comments (0) 0 ALUR-7.05% In a recent transaction filed with the Securities and Exchange Commission, Gaur Shantanu, the ...